FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top News Most Read Highlighted
Get Alerts CALI Hot Sheet
China Auto Logistic Inc. (Nasdaq: CALI) 82.3% HIGHER; moving higher, potentially due in part to a bullish blog post issued Monday morning.
Elecsys Corporation (Nasdaq: ESYS) 29.7% HIGHER; reported Q3 EPS of $0.18, versus $0.07 reported last year. Revenue for the quarter came in at $7.46 million, versus $5.22 million reported last year.
AEterna Zentaris Inc. (Nasdaq: AEZS) 23.1% LOWER; announced that an independent Data Safety Monitoring Board (“DSMB”) has recommended discontinuing the ongoing Phase 3 study comparing the efficacy and safety of perifosine to placebo when combined with bortezomib (Velcade) and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma. Based on the outcome of its pre-planned interim analysis of efficacy and safety, the DSMB recommended that patient enrollment be stopped and the study discontinued. The DSMB reported that it was highly unlikely the study would achieve a significant difference in its primary endpoint, progression free survival; no safety concerns were raised.
Verso Paper (NYSE: VRS) 18.9% HIGHER; moving higher following a slew of Form 4 filings made PAMT) 16.6% HIGHER; the company’s Board of Directors, upon recommendation of the Executive Committee of the Board of Directors, granted a stock option to purchase shares of common stock of the Company’s wholly-owned subsidiary, HyperSound Health, Inc., to Kenneth F. Potashner. Mr. Potashner serves as Executive Chairman of the Company and also serves as President of HHI. The option grant was made pursuant to HHI’s 2013 Equity Incentive Plan and is for an aggregate of 50 shares of common stock of HHI at an exercise price of $1,000.00 per share that was determined to be at or above the fair market value of the shares on the grant date. HHI has a total of 1,000 shares of common stock outstanding.
Simcere Pharmaceutical Group (NYSE: SCR) 15.6% HIGHER; announced that its Board of Directors has received a non-binding proposal letter from Mr. Jinsheng Ren, New Good Management Limited, Assure Ahead Investments Limited and its affiliates (the “Buyer Group”), pursuant to which the Buyer Group proposes to acquire all of the outstanding ordinary shares of the Company not currently owned by the Buyer Group, for $9.56 per American Depositary Share (“ADS”) or $4.78 per ordinary shares in cash.
Cardiovascular Systems, Inc. (CSI) (Nasdaq: CSII) 14.2% HIGHER; presented pivotal 30-day data from its ORBIT II study of severely calcified coronary lesions at the 2013 American College of Cardiology (ACC) conference in San Francisco. The Featured Clinical Research session presentation by Dr. Jeffrey Chambers of Metropolitan Heart and Vascular Institute, Minneapolis, demonstrated that CSI’s technology produced clinical outcomes that exceeded the trial’s two primary endpoints by a significant margin—within one of the most challenging patient populations to treat.
Canadian Solar, Inc. (Nasdaq: CSIQ) 10.9% LOWER; reported Q4 EPS of ($1.01), $0.06 worse than the analyst estimate of ($0.95). Revenue for the quarter came in at $294.8 million versus the consensus estimate of $318.53 million. Solar module shipments were 404 MW, compared to 384 MW in the third quarter of 2012. Sees Q113 shipments of 290-MW to 310-MW and FY13 shipments of approximately 1.6GW to 1.8GW, including modules used in our total solutions business.
James River Coal (Nasdaq: JRCC) 10.1% LOWER; Tudor Pickering cut its rating to Trim from Hold while Deutsche Bank lowered its price target from $3.25 down to $2.50 today.
Dicks Sporting Goods, Inc. (NYSE: DKS) 9.8% LOWER; reported Q4 EPS of $1.06, in-line with the analyst estimate of $1.06. Revenue for the quarter came in at $1.8 billion versus the consensus estimate of $1.86 billion. Comps up 1.2 percent. Sees FY2013 EPS of $2.84-$2.86, versus the consensus of $2.92. Sees comps up 2 to 3 percent. Dicks also sees Q1 2013 EPS of $0.47-$0.49, versus the consensus of $0.50. Sees comps down 2 to 1 percent, or flat to up 1 percent on an unadjusted basis.
Orient Paper, Inc. (NYSE: ONP) 9.4% LOWER; reported Q4 EPS of $0.11, versus $0.30 reported last year. Revenue for the quarter came in at $43.5 million, versus $38.9 million reported last year.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW